Digital pharmacy startup Hims & Hers Health now offering compounded GLP-1 weight loss injections with soaring stock prices
Digital pharmacy startup Hims & Hers Health now offering compounded GLP-1 weight loss injections with soaring stock prices

Introducing Weight Loss Injections

Well well well looks like Hims & Hers Health is stepping up their game by offering GLP 1 weight loss injections now. Guess they're not just about fixing erectile dysfunction and hair loss anymore! Watch out Shrek looks like there's competition in the weight loss department now.

Money Talks Shares Walk

Shares of Hims & Hers Health shot up more than 27% after the announcement. Donkey would be proud of these 'shrek tacular' numbers. Who knew weight loss injections could make investors jump for joy?

Supply and Demand

"What's up with the shortage of GLP 1 meds lately?" Donkey. The market's been tough but Hims & Hers CEO Andrew Dudum says they've got it under control. Looks like they're making moves in the swamp of pharmaceuticals.

FDA Approval... or Not

"FDA's got their eyes on you Hims & Hers!" Gingy. The FDA may not review compounded products but they're keeping an eye on the GLP 1 situation. Looks like it's time for some regulatory swamp cleaning!

Exclusive Partnerships

Dudum claims they've got an 'exclusivity' deal with a manufacturer for the compounded medications. Sounds like Hims & Hers has found their own version of Dragon guarding the supply chain. Smart move Shrek style!

The Weight Loss Quest Continues

"Onwards noble steed! To the land of thinner waistlines!" Puss in Boots. Hims & Hers expects big things from their weight loss program. Let's see if they can 'ogre'achieve their revenue goals!


Comments

  • No comments yet. Become a member to post your comments.